Table 3.
Posmiddleerative pain scores and narcotic use.
| Overall (N = 112) | PCA (N = 44) | TAP (N = 30) | PCEA (N = 38) | P-value | |
|---|---|---|---|---|---|
|
|
|
|
|
||
| Variable | Median (range) | Median (range) | Median (range) | Median (range) | |
| Day 0 | |||||
| Pain score | 4.8 (0–8.9) | 5.1 (0–8.3) | 4.9 (2.8–8.1) | 4.2 (1.0–8.9) | 0.292 |
| Narcotic usea (mg) | 11.3 (0–99) | 15.3 (1–46) | 6.5 (0–35) | 11 (0–99) | 0.014 |
| Day 1 | |||||
| Pain score | 3.9 (1.0–9.2) | 4.1 (1.0–9.2) | 4.5 (1.4–7.4) | 3.3 (1.4–7.4) | 0.046 |
| Narcotic usea (mg) | 6.1 (0–223) | 13.3 (0.3–108) | 9.7 (0.3–223) | 1.0 (0–47.5) | <0.0001 |
| Day 2 | |||||
| Pain score | 4.0 (1.0–8.3) | 4.0 (2.0–7.9) | 4.2 (1.0–8.3) | 3.0 (1.0–7.4) | 0.008 |
| Narcotic usea (mg) | 2.2 (0–204) | 3.3 (0–76) | 3.3 (0–204) | 1.2 (0–33) | 0.048 |
Bold data reflect significant results.
a
Systemic narcotic use converted to morphine-equivalents in milligrams.